SIFI SpA`s Akantior Receives Approval in Europe
29 Nov 2024 //
EMA
SIFI Announces Patent Allowance On Polihexanide For Europe
30 Sep 2024 //
PR NEWSWIRE
EC Authorizes Avanzanite Bioscience`s Orphan Drug AKANTIOR
27 Aug 2024 //
BUSINESSWIRE
SIFI Receives European Commission Approval for AKANTIOR®
26 Aug 2024 //
PR NEWSWIRE
SIFI Receives Positive Opinion On Orphan Drug For Fungal Keratitis
22 Jul 2024 //
PR NEWSWIRE
Avanzanite`s AKANTIOR Gets CHMP Opinion, Expands To 26 EU Countries
03 Jun 2024 //
BUSINESSWIRE
CHMP approves backing for first acanthamoeba keratitis treatment
03 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
SIFI`s AKANTIOR® For Acanthamoeba Keratitis Gets CHMP Positive Opinion
31 May 2024 //
PR NEWSWIRE
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
SIFI Reports Positive Results & Data from Completed PIII Trial of AKANTIOR
13 Oct 2022 //
PRNEWSWIRE
SIFI Announces Positive Topline Results of the Pivotal PhIII Study Polihexanide
19 Oct 2021 //
PRNEWSWIRE
Enforcement Report - Week of April 24, 2019
24 Apr 2019 //
FDA